Accueil › Cancer du poumon › Michigan › Flint
Essais cliniques pour Cancer du poumon à Flint, MI
10 études pour Cancer du poumon recherchent des participants dans et autour de Flint (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Recrutement en coursPhase 3
- Cancer Hematology Centers - Flint, Flint
- Genesys Hurley Cancer Institute, Flint
- Hurley Medical Center, Flint
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Cancer Hematology Centers - Flint, Flint
- Genesee Hematology Oncology PC, Flint
- Genesys Hurley Cancer Institute, Flint
- et 1 autres
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Recrutement en coursPhase 3
- Cancer Hematology Centers - Flint, Flint
- Genesys Hurley Cancer Institute, Flint
- Hurley Medical Center, Flint
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Recrutement en coursPhase 3
- Cancer Hematology Centers - Flint, Flint
- Genesys Hurley Cancer Institute, Flint
- Hurley Medical Center, Flint
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Recrutement en coursPhase 3
- Cancer Hematology Centers - Flint, Flint
- Genesys Hurley Cancer Institute, Flint
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Recrutement en coursPhase 3
- McLaren Cancer Institute-Flint, Flint
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Recrutement en coursPhase 3
- McLaren Cancer Institute-Flint, Flint
- McLaren Cancer Institute-Lapeer Region, Lapeer · à 19 mi
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Recrutement en coursPhase 2
- Cancer Hematology Centers - Flint, Flint
- Genesys Hurley Cancer Institute, Flint
- Hurley Medical Center, Flint
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Recrutement en coursPhase 2
- Cancer Hematology Centers - Flint, Flint
- Genesys Hurley Cancer Institute, Flint
- Hurley Medical Center, Flint
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Recrutement en coursPhase 2/3
- Cancer Hematology Centers - Flint, Flint
- Genesys Hurley Cancer Institute, Flint
Essais pour Cancer du poumon dans d'autres villes
- Houston, TX78 études
- Boston, MA62 études
- New York City, NY60 études
- Los Angeles, CA45 études
- Washington, DC41 études
- Arlington, VA41 études
- Chicago, IL41 études
- Nashville, TN40 études
- Baltimore, MD40 études
- St. Louis, MO39 études
- Columbus, OH37 études
- Philadelphia, PA36 études
Autres études à Flint
- Cancer du poumon non à petites cellules9 études
- Cancer du sein9 études
- Cancer de la prostate7 études
- Cancer colorectal6 études
- Leucémie aiguë myéloïde6 études
- Cancer (tous types)5 études
- Lupus4 études
- Carcinome épidermoïde de la tête et du cou4 études
- Cancer de l'hypopharynx4 études
- Cancer du larynx4 études
- Cancer de la bouche4 études
- Cancer du rein (carcinome à cellules rénales)3 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.